COMPLEMENT SYSTEM PROTEIN C4 AND SUSCEPTIBILITY TO HYDRALAZINE-INDUCED SYSTEMIC LUPUS ERYTHEMATOSUS
- 1 April 1989
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 333 (8644), 922-924
- https://doi.org/10.1016/s0140-6736(89)92506-3
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Relationship between C4 null genes, HLA-D region antigens, and genetic susceptibility to systemic lupus erythematosus in Caucasian and Black AmericansAmerican Journal Of Medicine, 1986
- Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility.BMJ, 1983
- Disease Associations with Complotypes, Supratypes and HaplotypesImmunological Reviews, 1983
- Extended HLA/complement allele haplotypes: evidence for T/t-like complex in man.Proceedings of the National Academy of Sciences, 1983
- HYDRALAZINE-INDUCED SYSTEMIC LUPUS ERYTHEMATOSUS: INFLUENCE OF HLA-DR AND SEX ON SUSCEPTIBILITYThe Lancet, 1980
- Disease and Acetylation PolymorphismClinical Pharmacokinetics, 1977
- Inherited deficiency of the second component of complement. Rheumatic disease associations.JCI Insight, 1976
- Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritisAmerican Journal Of Medicine, 1973
- GENETIC VARIATIONS IN THE ACETYLATION OF ISONIAZID AND OTHER DRUGSAnnals of the New York Academy of Sciences, 1968
- SYNDROME SIMULATING COLLAGEN DISEASE CAUSED BY HYDRALAZINE (APRESOLINE)JAMA, 1954